WHIPgroup has filed a patent infringement lawsuit on behalf of its client RegenLab USA LLC in the Southern District of New York, Case No. 17-cv-03845 (S.D.N.Y.) (filed May 22, 2017). RegenLab is a leading innovator of medical and pharmaceutical products that it distributes under the world-famous REGENLAB® brand. RegenLab developed a new and extremely effective way to enhance platelet rich plasma production that is patented in U.S. Pat. No. 8,529,957 (“the ‘957 patent”). The complaint alleges that Raj Kanodia, M.D., Garden City Dermatology, P.C., and Trifecta Health Medical P.C. infringe the ‘957 patent with their commercial promotion, use, and sale of a product called “Eclipse PRP.”
WHIPgroup successfully obtained an Order of Preliminary Injunction in connection with a Complaint and Emergency Motion for Temporary Restraining Order and Preliminary Injunction filed in the U.S. District Court for the Northern District of Georgia [Read More…]
On January 26, 2023, Wes Whitmyer of WHIPgroup will present on patents and trademarks at TechXel’s Venture Expert Series. For event details, click here. View the flyer.
WHIPgroup continues to represent its client’s best interests, filing counterclaims in an ongoing arbitration administered by the American Arbitration Association. WHIPgroup brought claims for breach of contract and unjust enrichment as well as tortious interference [Read More…]